nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Amnesia—Carmustine—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Diatrizoate—Swelling—Mitoxantrone—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Diatrizoate—Eruption—Methotrexate—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Diatrizoate—Renal failure acute—Mitoxantrone—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Diatrizoate—Anaemia—Teniposide—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Diatrizoate—Agitation—Teniposide—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Diatrizoate—Bronchospasm—Bleomycin—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Diatrizoate—Chills—Fludarabine—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Diatrizoate—Arrhythmia—Fludarabine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Diatrizoate—Face oedema—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Diatrizoate—Leukopenia—Teniposide—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Diatrizoate—Hypertension—Teniposide—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Diatrizoate—Paralysis—Methotrexate—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Diatrizoate—Chest pain—Teniposide—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Diatrizoate—Cardiac arrest—Vincristine—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Diatrizoate—Cyanosis—Methotrexate—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Diatrizoate—Confusional state—Teniposide—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Diatrizoate—Oedema—Teniposide—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Diatrizoate—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Bleomycin—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Diatrizoate—Anaemia—Fludarabine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Diatrizoate—Infection—Teniposide—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Myocardial infarction—Bleomycin—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Diatrizoate—Agitation—Fludarabine—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Diatrizoate—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Diatrizoate—Tachycardia—Teniposide—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Diatrizoate—Hyperhidrosis—Teniposide—lymphatic system cancer	0.003	0.003	CcSEcCtD
Diatrizoate—Leukopenia—Fludarabine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Diatrizoate—Haematuria—Bleomycin—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Diatrizoate—Pruritus—Mechlorethamine—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Diatrizoate—Cough—Fludarabine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Diatrizoate—Hypotension—Teniposide—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Diatrizoate—Convulsion—Fludarabine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Diatrizoate—Necrosis—Methotrexate—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Diatrizoate—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Diatrizoate—Neutropenia—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Diatrizoate—Haemoglobin—Bleomycin—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Diatrizoate—Haemorrhage—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Diatrizoate—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Diatrizoate—Dyspnoea—Teniposide—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Diatrizoate—Petechiae—Methotrexate—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Diatrizoate—Confusional state—Fludarabine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Diatrizoate—Neutropenia—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Diatrizoate—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Diatrizoate—Oedema—Fludarabine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Diatrizoate—Infection—Fludarabine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Diatrizoate—Renal failure—Carmustine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Diatrizoate—Vomiting—Mechlorethamine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Diatrizoate—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Diatrizoate—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Diatrizoate—Rash—Mechlorethamine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Diatrizoate—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Diatrizoate—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Diatrizoate—Speech disorder—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Diatrizoate—Flushing—Bleomycin—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Diatrizoate—Extravasation—Methotrexate—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Diatrizoate—Myocardial infarction—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Diatrizoate—Feeling abnormal—Teniposide—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Diatrizoate—Chills—Bleomycin—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Diatrizoate—Sweating—Vincristine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Diatrizoate—Renal failure—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Diatrizoate—Nausea—Mechlorethamine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Diatrizoate—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Diatrizoate—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Diatrizoate—Haemoglobin—Carmustine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Diatrizoate—Urticaria—Teniposide—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Diatrizoate—Oliguria—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Diatrizoate—Haemorrhage—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Body temperature increased—Teniposide—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Erythema—Bleomycin—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Paraesthesia—Fludarabine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Diatrizoate—Sweating—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Diatrizoate—Dyspnoea—Fludarabine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Diatrizoate—Haematuria—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Diatrizoate—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Diatrizoate—Pain—Fludarabine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Diatrizoate—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Diatrizoate—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Diatrizoate—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Diatrizoate—Flushing—Carmustine—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Diatrizoate—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Diatrizoate—Anaemia—Bleomycin—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Diatrizoate—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Diatrizoate—Asthenia—Teniposide—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Diatrizoate—Pruritus—Teniposide—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Arrhythmia—Carmustine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Leukopenia—Bleomycin—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Diatrizoate—Body temperature increased—Fludarabine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Diatrizoate—Erythema—Carmustine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Diatrizoate—Cough—Bleomycin—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Diatrizoate—Diarrhoea—Teniposide—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Diatrizoate—Chest pain—Bleomycin—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Diatrizoate—Coma—Methotrexate—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Diatrizoate—Chills—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Diatrizoate—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Diatrizoate—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Confusional state—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Diatrizoate—Tremor—Carmustine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Diatrizoate—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.002	0.002	CcSEcCtD
Diatrizoate—Oedema—Bleomycin—lymphatic system cancer	0.002	0.002	CcSEcCtD
Diatrizoate—Erythema—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Diatrizoate—Infection—Bleomycin—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Diatrizoate—Anaemia—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Diatrizoate—Vomiting—Teniposide—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Diatrizoate—Agitation—Carmustine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Diatrizoate—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Diatrizoate—Asthenia—Fludarabine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Diatrizoate—Rash—Teniposide—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Dermatitis—Teniposide—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Headache—Teniposide—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Pruritus—Fludarabine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Diatrizoate—Leukopenia—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Diatrizoate—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Diatrizoate—Anaemia—Vincristine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Diatrizoate—Agitation—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Hypotension—Bleomycin—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Diarrhoea—Fludarabine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Diatrizoate—Convulsion—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Diatrizoate—Hypertension—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Diatrizoate—Nausea—Teniposide—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Diatrizoate—Anaemia—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Diatrizoate—Leukopenia—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Chest pain—Carmustine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Diatrizoate—Paraesthesia—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Dyspnoea—Bleomycin—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Diatrizoate—Renal failure acute—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Diatrizoate—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Diatrizoate—Convulsion—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Diatrizoate—Hypertension—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Diatrizoate—Confusional state—Carmustine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Diatrizoate—Oedema—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Diatrizoate—Cough—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Infection—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Vomiting—Fludarabine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Convulsion—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Diatrizoate—Rash—Fludarabine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Diatrizoate—Dermatitis—Fludarabine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Diatrizoate—Hypertension—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Diatrizoate—Pain—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Headache—Fludarabine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Tachycardia—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Diatrizoate—Chest pain—Mitoxantrone—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Oedema—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Diatrizoate—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Diatrizoate—Infection—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Confusional state—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Hypotension—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Oedema—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Diatrizoate—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Diatrizoate—Nausea—Fludarabine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Diatrizoate—Infection—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Diatrizoate—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Diatrizoate—Shock—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Diatrizoate—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Diatrizoate—Urticaria—Bleomycin—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Diatrizoate—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Body temperature increased—Bleomycin—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Diatrizoate—Paraesthesia—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Diatrizoate—Hypotension—Vincristine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Dyspnoea—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Diatrizoate—Hypotension—Mitoxantrone—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Diatrizoate—Paraesthesia—Vincristine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Diatrizoate—Pain—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Diatrizoate—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Diatrizoate—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Diatrizoate—Feeling abnormal—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Diatrizoate—Asthenia—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Diatrizoate—Pain—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Diatrizoate—Asthma—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Diatrizoate—Pruritus—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Diatrizoate—Pain—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Diatrizoate—Body temperature increased—Carmustine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Diatrizoate—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Diatrizoate—Neutropenia—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Body temperature increased—Vincristine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Urticaria—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Diatrizoate—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Diatrizoate—Vomiting—Bleomycin—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Rash—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Diatrizoate—Dermatitis—Bleomycin—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Diatrizoate—Asthenia—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Renal failure—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Diatrizoate—Sweating—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Haematuria—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Asthenia—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Diarrhoea—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Nausea—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Asthenia—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Dizziness—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Diatrizoate—Haemoglobin—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Diarrhoea—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Haemorrhage—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Vomiting—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Dizziness—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Diatrizoate—Rash—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Diatrizoate—Dermatitis—Carmustine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Diatrizoate—Headache—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Vomiting—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Diatrizoate—Rash—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Dermatitis—Vincristine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Headache—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Nausea—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Diatrizoate—Vomiting—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Diatrizoate—Rash—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Chills—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Headache—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Erythema—Methotrexate—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Diatrizoate—Nausea—Vincristine—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Diatrizoate—Dysgeusia—Methotrexate—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Diatrizoate—Nausea—Mitoxantrone—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Diatrizoate—Anaemia—Methotrexate—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Diatrizoate—Leukopenia—Methotrexate—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Diatrizoate—Cough—Methotrexate—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Diatrizoate—Convulsion—Methotrexate—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Diatrizoate—Chest pain—Methotrexate—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Diatrizoate—Confusional state—Methotrexate—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Diatrizoate—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Diatrizoate—Infection—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Diatrizoate—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Diatrizoate—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Diatrizoate—Hypotension—Methotrexate—lymphatic system cancer	0.000755	0.000755	CcSEcCtD
Diatrizoate—Paraesthesia—Methotrexate—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Diatrizoate—Dyspnoea—Methotrexate—lymphatic system cancer	0.00072	0.00072	CcSEcCtD
Diatrizoate—Pain—Methotrexate—lymphatic system cancer	0.000691	0.000691	CcSEcCtD
Diatrizoate—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000666	0.000666	CcSEcCtD
Diatrizoate—Urticaria—Methotrexate—lymphatic system cancer	0.000642	0.000642	CcSEcCtD
Diatrizoate—Body temperature increased—Methotrexate—lymphatic system cancer	0.000639	0.000639	CcSEcCtD
Diatrizoate—Asthenia—Methotrexate—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Diatrizoate—Pruritus—Methotrexate—lymphatic system cancer	0.000572	0.000572	CcSEcCtD
Diatrizoate—Diarrhoea—Methotrexate—lymphatic system cancer	0.000553	0.000553	CcSEcCtD
Diatrizoate—Dizziness—Methotrexate—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Diatrizoate—Vomiting—Methotrexate—lymphatic system cancer	0.000514	0.000514	CcSEcCtD
Diatrizoate—Rash—Methotrexate—lymphatic system cancer	0.000509	0.000509	CcSEcCtD
Diatrizoate—Dermatitis—Methotrexate—lymphatic system cancer	0.000509	0.000509	CcSEcCtD
Diatrizoate—Headache—Methotrexate—lymphatic system cancer	0.000506	0.000506	CcSEcCtD
Diatrizoate—Nausea—Methotrexate—lymphatic system cancer	0.00048	0.00048	CcSEcCtD
